PXDN and head and neck carcinoma: As shown in Figure 2A, there were significant differences in the PXDN protein expressions of seven tumors, including those of ovarian cancer, RCC, UCEC, pancreatic cancer, head and neck carcinoma, glioblastoma, and liver cancer.